A61L 33/06 Use of macromolecular materials (grafting of a monomer onto the substrate A61L33/0088)
Introduced: January 2000
Title
Titles differ between systems:
IPC: Use of macromolecular materials
CPC: Use of macromolecular materials (grafting of a monomer onto the substrate A61L33/0088)
Full Title
Full titles differ between systems:
Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment > Use of macromolecular materials
Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment > Use of macromolecular materials (grafting of a monomer onto the substrate A61L33/0088)
CPC subdivides this area 3x more granularly than IPC with 3 additional codes.
3 codes are CPC-only extensions.
IPC defines codes here since 2000.
Child Classifications
Navigate with arrow keys, Enter to open
- A61L 33/12 Polypeptides, proteins or derivatives thereof since 2000 +4 CPC IPC+CPC Available in IPC and CPC
Top Applicants
Top Applicants (IPC)
Class A61,2013–2023, worldwide · Source: EPO PATSTAT
- PHILIPS ELECTRONICS NL 18,523
- NOVARTIS CH 14,253
- COVIDIEN US 13,953
- ROCHE CH 12,005
- CHINESE ACADEMY OF SCIENCES 11,955
- UNIVERSITY OF CALIFORNIA US 11,692
- HARVARD UNIVERSITY US 11,596
- L'OREAL FR 11,593
- P&G (PROCTER & GAMBLE COMPANY) US 11,297
- OLYMPUS CORPORATION JP 9,594
Top Applicants (CPC)
Class A61,2013–2023, worldwide · Source: EPO PATSTAT
- PHILIPS ELECTRONICS NL 20,621
- NOVARTIS CH 15,792
- ROCHE CH 14,303
- COVIDIEN US 13,862
- HARVARD UNIVERSITY US 13,454
- UNIVERSITY OF CALIFORNIA US 12,798
- P&G (PROCTER & GAMBLE COMPANY) US 12,140
- L'OREAL FR 11,800
- OLYMPUS CORPORATION JP 9,894
- BOSTON SCIENTIFIC SCIMED US 9,513